Table 1.
The mean and standard deviation of the baseline characteristics of type 2 diabetes patients
| Variable | Category | Group | P-value | |
|---|---|---|---|---|
| Vitamin D (N = 42) |
Placebo (N = 43) |
|||
| Age (Y) | – | 50.36 (10.2) | 50.05 (10.7) | 0.892* |
| Weight (kg) | – | 77.38 (10.9) | 79.27 (11.6) | 0.442* |
| Height (cm) | – | 159.35 (8.0) | 158.77 (7.6) | 0.736* |
| BMI (kg/m 2)) | – | 30.43 (3.2) | 31.37 (3.4) | 0.194* |
| Disease duration (months) | – | 65.52 (38.5) | 67.02 (35.4) | 0.664* |
| Medications (per day) | Metformin (500 mg/d) | 2.11 (1.13) | 2.51 (1.26) | 0.135* |
| Glibenclamide (5 mg/d) | 1.31 (0.94) | 0.95 (0.78) | ||
| Gender | Male | 7.00 (16.7) | 8.00 (18.6) | 0.815** |
| Female | 35.00 (83.3) | 35.00 (81.4) | ||
| Employment status | Unemployed | 32.00 (76.2) | 32.00 (74.4) | 0.850** |
| employed | 10.00 (23.8) | 11.00 (25.6) | ||
*Independent t-test; **Chi-square test, Y Year, kg Kilogram, cm Centimeter, BMI Body mass index, mg Milligram